Clinical Trial Update: VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) [NA]

View source ↗

Summary

The v-ASCERTAIN implementation study sponsored by Monash University has been terminated, involving conditions including atherosclerotic cardiovascular disease, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Cerebrovascular Disease
• Coronary Heart Disease
• Peripheral Arterial Disease

Snippet

Sponsor: Monash University | Conditions: Atherosclerotic Cardiovascular Disease (ASCVD), Coronary Heart Disease (CHD) | NA | Status: TERMINATED